Prescription of biphosphonates for use in cancerology in ambulatory medicine. A study by the health insurance medical services;Prescription des biphosphonates a visee cancerologique en pratique de ville. Une etude des services medicaux de l'assurance-maladie

Presse Medicale

Volumn 25, Issue 24, 1996, Pages 1101-1104

  Vicrey, C ^a,d   Bayet, J F ^b   Extra, J M ^c   Grebet, J ^a   Ricard, J L ^a   Vinot, M ^a   Ouanhnon, P ^b   Kurz, H ^b   Vernaz, J ^b  

^a Centre Paris Pleyel   (France)

^b Caisse Ctrl Mutualite Social A   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d CANAM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID;

AMBULATORY CARE; ARTICLE; CANCER; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRACTICE GUIDELINE; PRESCRIPTION; AGED; DRUG UTILIZATION; FEMALE; FRANCE; GENERAL PRACTICE; HEALTH INSURANCE; MALE; NEOPLASM; ONCOLOGY;

AGED; AMBULATORY CARE; DIPHOSPHONATES; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; INSURANCE, HEALTH; MALE; MEDICAL ONCOLOGY; NEOPLASMS;

EID: 0030572392     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Droz JP, Kramar A, Wibault P et al. Stratégie thérapeutique dans le cancer du rein métastasique. Rev Prat (Paris) 1992 ; 42:1253-7.
2. Ravaud P, Roux C. Os et myélome. Rev Prat (Paris) 1993 ; 43:293-7.
3. Liens D, Delmas PD. Les biphosphonates dans le traitement des métastases ostéolytiques. Rev Prat (Paris) 1993 ; 43:1259-61.
4. Ménégaux F, Chigot JP. Glandes parathyroïdes : anatomie, histologie, chirurgie. Encycl Med Chir (Paris), Endocrinologie-nutrition, 1994 :10-011-A-10.
5. Rayon des nouveautés : Clastoban gélules. Rev Prescrire 1991 ; 11:349.
6. Delmas PD, Meunier PJ. Le dichlorométhylène diphosphonate (clodronate) en thérapeutique. Boehringer Mannheim France, Lyon 1981.
7. Kanis JA, McClosey EV. The use of clodronate in disorders of calcium and skeletal metabolism. In: Calcium metabolism. Prog Basic Clin Pharmacol Basel, Karger, 1990 ; 4:136.
8. Fleisch H. The use of biphosphonates in osteoporosis. Br J Clin Pract 1994 ; 48:323-6.
9. Chappard D, Minaire P, Privat C et al. Effects of tiludronate on bone loss in paraplegic patients. J Bone Miner Res 1995 ; 10:112-18.
10. Eggelmeijer F, Papapoulos SE, Van Paassen HC. Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study. J Rheumatol 1994 ; 21:2016-20.
11. Paterson AHG, Powles TJ, Kanis JA et al. Double-blind controlled trial of oral Clodronate in patients with bone métastases from breast cancer. J Clin Oncol 1993 ; 11:59-65.
12. Clarke NW, Holbrook IB, McClure J et al. Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study. Br J Cancer 1991 ; 63:420-3.